GNI Group (FRA:3G6) Cyclically Adjusted Revenue per Share: €1.66 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3G6 GNI Group Ltd FRA:3G6
84 GF Score
Price €12.80
GF Value €15.65
! 5 Warning Signs
View Full Analysis

What is GNI Group Cyclically Adjusted Revenue per Share?

GNI Group FRA:3G6 -4.48% 84 Cyclically Adjusted Revenue per Share is €1.66 as of Mar. 2026. GuruFocus rates FRA:3G6 with a GF Score™ of 84/100 and a GF Value™ of €15.65. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

GNI Group's adjusted revenue per share for the three months ended in Mar. 2026 was €0.541. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €1.66 for the trailing ten years ended in Mar. 2026.

During the past 12 months, GNI Group's average Cyclically Adjusted Revenue Growth Rate was 20.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 30.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 35.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of GNI Group was 45.40% per year. The lowest was 30.50% per year. And the median was 41.30% per year.

As of today (2026-07-29), GNI Group's current stock price is €12.80. GNI Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €1.66. GNI Group's Cyclically Adjusted PS Ratio of today is 7.71.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of GNI Group was 81.59. The lowest was 6.84. And the median was 15.28.


GNI Group  (FRA:3G6) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

GNI Group's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=12.80/1.66
=7.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of GNI Group was 81.59. The lowest was 6.84. And the median was 15.28.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


GNI Group Cyclically Adjusted Revenue per Share Related Terms


GNI Group Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for GNI Group's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GNI Group Cyclically Adjusted Revenue per Share Chart

GNI Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.71 0.92 1.19 1.52 1.58

GNI Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.52 1.55 1.57 1.58 1.66

FRA:3G6 vs VRTX, REGN, RVMD: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, GNI Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GNI Group Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GNI Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where GNI Group's Cyclically Adjusted PS Ratio falls into.


FRA:3G6
84GF Score
GNI Group Ltd FRA:3G6
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GNI Group Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, GNI Group's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.541/112.7000*112.7000
=0.541

Current CPI (Mar. 2026) = 112.7000.

GNI Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.058 98.100 0.067
201609 0.073 98.000 0.084
201612 0.114 98.400 0.131
201703 0.085 98.100 0.098
201706 0.082 98.500 0.094
201709 0.142 98.800 0.162
201712 0.219 99.400 0.248
201803 0.191 99.200 0.217
201806 0.217 99.200 0.247
201809 0.275 99.900 0.310
201812 0.264 99.700 0.298
201903 0.299 99.700 0.338
201906 0.361 99.800 0.408
201909 0.368 100.100 0.414
201912 0.386 100.500 0.433
202003 0.400 100.300 0.449
202006 0.418 99.900 0.472
202009 0.459 99.900 0.518
202012 0.495 99.300 0.562
202103 0.631 99.900 0.712
202106 0.407 99.500 0.461
202109 0.491 100.100 0.553
202112 0.504 100.100 0.567
202203 0.631 101.100 0.703
202206 0.626 101.800 0.693
202209 0.673 103.100 0.736
202212 0.679 104.100 0.735
202303 0.617 104.400 0.666
202306 1.356 105.200 1.453
202309 0.836 106.200 0.887
202312 0.674 106.800 0.711
202403 0.703 107.200 0.739
202406 0.681 108.200 0.709
202409 0.689 108.900 0.713
202412 0.768 110.700 0.782
202503 0.658 111.100 0.667
202506 0.827 111.700 0.834
202509 0.798 112.000 0.803
202512 0.781 113.000 0.779
202603 0.541 112.700 0.541

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €1.66 mean?
GNI Group (FRA:3G6) has a Cyclically Adjusted Revenue per Share of €1.66 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on GNI Group and its competitors.
Is GNI Group's Cyclically Adjusted Revenue per Share too high?
GNI Group's current Cyclically Adjusted Revenue per Share is €1.66. Overall, GNI Group has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does GNI Group's Cyclically Adjusted Revenue per Share compare to VRTX and REGN?
GNI Group's Cyclically Adjusted Revenue per Share of €1.66 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on GNI Group and its competitors. GNI Group's current Cyclically Adjusted Revenue per Share is €1.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GNI Group stock overvalued right now?
GNI Group (FRA:3G6) has a current Cyclically Adjusted Revenue per Share of €1.66. The stock's GF Value™ is €15.65, compared to a current price of €12.80 — trading 18.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €1.66. GNI Group's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For GNI Group (FRA:3G6), the current Cyclically Adjusted Revenue per Share is €1.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GNI Group (FRA:3G6) Overvalued in 2026?

Based on GuruFocus' analysis, GNI Group stock appears to be undervalued. The current stock price of €12.80 is trading 18.2% below its estimated GF Value™ of €15.65.

Key valuation signals for FRA:3G6:

  • Cyclically Adjusted Revenue per Share: €1.66
  • GF Value™: €15.65 vs. price of €12.80 (18.2% below fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the FRA:3G6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


GNI Group Business Description

Other Exchanges 2160:Japan
Address 2-2-2 Nihonbashi Honcho, 3rd Floor, Nihonbashi Honcho YS Building, Chuo-ku, Tokyo, JPN, 103-0023
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
84GF Score

Get the complete analysis for FRA:3G6

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.80
Price
€15.65
GF Value